Saturday, 13 September 2014
ECTRIMS 2014: NEDA is getting more traction
NEDA is here, it here to stay and it is evolving. #MSBlog #MSResearch
"As promised; my platform presentation from yesterday. It is clear that treat-2-target is getting a lot of attention at this meeting as well as end-organ damage. There was a prestentation yesterday by Professor Ludwig Kappos to try and incorporate brain atrophy into the measurement; i.e. NEDA-4. This indicates that NEDA is behaving the way it should an evolving over time."
"As promised; my platform presentation from yesterday. It is clear that treat-2-target is getting a lot of attention at this meeting as well as end-organ damage. There was a prestentation yesterday by Professor Ludwig Kappos to try and incorporate brain atrophy into the measurement; i.e. NEDA-4. This indicates that NEDA is behaving the way it should an evolving over time."
Multiple Sclerosis Research: ECTRIMS 2014: NEDA is getting more traction:
Gavin Giovannoni
@GavinGiovannoni
Professor of Neurology, Barts and The London. I spend a lot of time thinking about multiple sclerosis. It is my ambition to prevent this disease.
London, UK
Joined July 2009
Source: http://multiple-sclerosis-research.blogspot.ca/2014/09/ectrims-2014-neda-is-getting-more.html?spref=tw
LINK: https://twitter.com/GavinGiovannoni
'via Blog this'
No comments:
Post a Comment